Perkant Tech Plans Market Expansion With New Seed Funding

Perkant Tech, inventors of a leading AI-Enabled Med-tech Multi-disease Prognostic Health Platform, has raised INR 6.6 Crore in a seed funding round led by YourNest Venture Capital. This round includes contributions of INR 5 crore from YourNest, INR 1 crore from the Government of India’s Atal New India Challenge (AIM, Niti Aayog), INR 35 lakh from Villgro Foundation, and INR 25 lakh from the accelerator Sanchi Connect who partnered with YourNest in its Velocity fast-track funding program.

Indore-based Perkant Tech was founded during COVID19 in 2020 by Lokant Jain and Saniya Jeswani, two young engineers in their final year of college. It offers a medical device with an exclusive suite of AI-augmented health solutions which empowers individuals and healthcare providers with real-time, predictive health insights, ranging from preventative screenings to comprehensive monitoring. This sustainable, upgradable platform redefines healthcare with precision, adaptability and scalability, bridging critical gaps in accessibility and supporting a future of equitable healthcare for all.

This investment will enable Perkant Tech to enhance its AI-powered prognostic technology, accelerate the R&D efforts and support market expansion, customer acquisition strategies as the company gears up for its commercial launch following successful pilots with world-class partners. Additionally, the funds will also be allocated towards technology upgrades and software development to ensure seamless integration, real-time updates, and personalized health insights, preparing the company’s solutions for widespread adoption.

Saniya Jeswani, Co-founder & CEO, Perkant Tech, said, “This investment marks a pivotal step in a journey that began for Lokant and me in our early twenties, driven by a vision to make healthcare truly proactive and universally accessible. With this support, our dedication to advancing prognostic technology reaches new heights. We are fuelled by a passion to deliver predictive health insights that empower individuals everywhere—even in the remotest corners of the world. This isn’t just an investment in technology; it’s a commitment to a future where accessible, life-enhancing healthcare is within reach for all.” 

Dr. Vivek Mansingh, General Partner, YourNest, said, “We are excited to back Perkant Tech as they revolutionize healthcare accessibility. Their innovative, AI-powered health screening device addresses a critical need with unmatched scalability and affordability, and we are confident in their ability to drive significant impact and growth in the healthcare sector.”

Perkant Tech holds a granted Indian patent (Application: 526020) and a pending U.S. patent (Application: 18/033,887) for an advanced apparatus designed to measure and acquire distress data from the human body, encompassing both psychological and physiological indicators. Aligned with the government’s National Digital Health Mission (NDHM), Perkant Tech’s integrated platform of measures, tracks and analyzes essential health vitals, redefining primary and preventive care delivery across rural and urban deployments. At the heart of this suite is Perkant Tech's flagship invention, Abhay Parimiti—patented in India and the US—which provides automated health assessments in under 60 seconds, making healthcare insights accessible, rapid and impactful.

Perkant Tech’s system serves as a digital doctor for India, powered by patented AI-driven multi-disease prognostic technology, bridging healthcare gaps in underserved regions where medical infrastructure and personnel are scarce. The key focus areas include advancing product research and development to maximise the capabilities of its health monitoring systems. The startup aims to expand beyond core metrics such as cardiac and respiratory health, delving into specific disease detection, early onset identification and recovery tracking. Its vision is to develop technology that serves as an early-stage indicator for conditions traditionally requiring invasive testing, pushing the boundaries of non-invasive health monitoring.